Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07008781 · ClinicalTrials.gov registry record · NA

A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening

A NA study of Cancer, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT07008781: Recruiting NA study of Cancer, sponsored by Rutgers, The State University of New Jersey.

NCT07008781 is a NA study of Cancer that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 84 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07008781, a NA study of Cancer, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.

Primary Outcome

% of adults who schedule or conduct cancer screening 2 weeks post-intervention

Conditions Studied

Cancer

Interventions

  • BEHAVIORAL Youth-led cancer screening intervention

Study Locations (1)

New Jersey

  • New Brunswick Health Sciences Technology High School - New Brunswick

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2025-05-30
Est. Completion 2026-02
Phase NA
Rutgers, The State University of New Jersey

413 total trials

What NCT07008781 shows while recruiting

NCT07008781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Youth-led cancer screening intervention is the first listed.

NCT07008781 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT07008781 about?

NCT07008781 is a clinical study titled "A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening". This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.

What is the current status of trial NCT07008781?

This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-05-30. Estimated completion is 2026-02.

What conditions does trial NCT07008781 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT07008781?

The interventions under investigation include: Youth-led cancer screening intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07008781?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07008781 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07008781's enrollment target sits among peer trials

84 345th of 615 higher than 270 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07008781

Source: ClinicalTrials.gov NCT07008781, the US trial registry maintained by the National Library of Medicine. NCT07008781 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.